Cargando…

Serum Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1) Is Associated with Atherosclerosis Severity in Coronary Artery Disease

Risk-factor-based scoring systems for atherosclerotic coronary artery disease (CAD) remain concerningly inaccurate at the level of the individual and would benefit from the addition of biomarkers that correlate with atherosclerosis burden directly. We hypothesized that serum soluble lectin-like oxid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kott, Katharine A., Genetzakis, Elijah, Gray, Michael P., Hansen, Peter, McGuire, Helen M., Yang, Jean Y., Grieve, Stuart M., Vernon, Stephen T., Figtree, Gemma A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452248/ https://www.ncbi.nlm.nih.gov/pubmed/37627252 http://dx.doi.org/10.3390/biom13081187

Ejemplares similares

Circulating Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1): A Diagnostic Indicator across the Spectrum of Acute Coronary Syndrome
por: Kumar, Sandeep, et al.
Publicado: (2021)

sLOX-1: A Molecule for Evaluating the Prognosis of Recurrent Ischemic Stroke
por: Zheng, Yangmin, et al.
Publicado: (2021)

Association of the LOX-1 rs1050283 Polymorphism with Risk for Atherosclerotic Cerebral Infarction and its Effect on sLOX-1 and LOX-1 Expression in a Chinese Population
por: Guo, Xin, et al.
Publicado: (2017)

Association between plasma sLOX-1 concentration and arterial stiffness in middle-aged and older individuals
por: Otsuki, Takeshi, et al.
Publicado: (2015)

Correlation of sLOX-1 Levels and MR Characteristics of Culprit Plaques in Intracranial Arteries with Stroke Recurrence
por: Ren, Kaixuan, et al.
Publicado: (2023)

Role of sLOX‐1 in intracranial artery stenosis and in predicting long‐term prognosis of acute ischemic stroke
por: Li, Xian‐Mei, et al.
Publicado: (2017)

Proteolytic Regulation of the Lectin-Like Oxidized Lipoprotein Receptor LOX-1
por: Mentrup, Torben, et al.
Publicado: (2021)

Expression of Serum sLOX-1 in Patients with Non-Small-Cell Lung Cancer and Its Correlation with Lipid Metabolism
por: Hao, Fangfang, et al.
Publicado: (2022)

Novel Strategies in the Early Detection and Treatment of Endothelial Cell-Specific Mitochondrial Dysfunction in Coronary Artery Disease
por: Lee, Weiqian E., et al.
Publicado: (2023)

Serum levels of sLOX‐1 and Lp‐PLA2 can predict the prognosis of acute cerebral infarction with a high specificity
por: Yan, Ping, et al.
Publicado: (2022)

Single‐Cell Immune Profiling in Coronary Artery Disease: The Role of State‐of‐the‐Art Immunophenotyping With Mass Cytometry in the Diagnosis of Atherosclerosis
por: Kott, Katharine A., et al.
Publicado: (2020)

Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention
por: Zhao, Zi-wen, et al.
Publicado: (2019)

Association of Global Coagulation Profiles With Cardiovascular Risk Factors and Atherosclerosis: A Sex Disaggregated Analysis From the BioHEART‐CT Study
por: Kott, Katharine A., et al.
Publicado: (2021)

LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013)

Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases
por: Pirillo, Angela, et al.
Publicado: (2013)

Patient Endothelial Colony-Forming Cells to Model Coronary Artery Disease Susceptibility and Unravel the Role of Dysregulated Mitochondrial Redox Signalling
por: Besnier, Marie, et al.
Publicado: (2021)

LOX-1: Implications in atherosclerosis and myocardial ischemia
por: Sharma, Tanya, et al.
Publicado: (2022)

Chronic Aerobic Exercise Decreases Lectin-Like Low Density Lipoprotein (LOX-1) Receptor Expression in Heart of Diabetic Rat
por: Riahi, Simin, et al.
Publicado: (2016)

LOX-1: Regulation, Signaling and Its Role in Atherosclerosis
por: Kattoor, Ajoe John, et al.
Publicado: (2019)

Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Level is Related to Clinical Prognosis In Patients with Acute Atherosclerosis-related Ischemic Stroke
por: Yang, Xiaoli, et al.
Publicado: (2021)

Mass cytometry analysis reveals altered immune profiles in patients with coronary artery disease
por: Kott, Katharine A, et al.
Publicado: (2023)

Unveiling LOX-1 receptor interplay with nanotopography: mechanotransduction and atherosclerosis onset
por: Di Rienzo, Carmine, et al.
Publicado: (2013)

Celastrol Prevents Atherosclerosis via Inhibiting LOX-1 and Oxidative Stress
por: Gu, Lei, et al.
Publicado: (2013)

Associations of Tissue and Soluble LOX‐1 with Human Abdominal Aortic Aneurysm
por: Hofmann, Anja, et al.
Publicado: (2023)

Mannose-Binding Lectin Reduces Oxidized Low-Density Lipoprotein Induced Vascular Endothelial Cells Injury by Inhibiting LOX1-ox-LDL Binding and Modulating Autophagy
por: Zhou, Xuelian, et al.
Publicado: (2023)

The Translation and Commercialisation of Biomarkers for Cardiovascular Disease—A Review
por: Saleh, Soloman, et al.
Publicado: (2022)

Metabolic Signatures in Coronary Artery Disease: Results from the BioHEART-CT Study
por: Vernon, Stephen T., et al.
Publicado: (2021)

Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Is Inversely Correlated with the Activity of ANCA-Associated Vasculitis
por: Yoon, Taejun, et al.
Publicado: (2020)

Dihydrotanshinone I Attenuates Atherosclerosis in ApoE-Deficient Mice: Role of NOX4/NF-κB Mediated Lectin-Like Oxidized LDL Receptor-1 (LOX-1) of the Endothelium
por: Zhao, Wenwen, et al.
Publicado: (2016)

Fisetin ameliorates atherosclerosis by regulating PCSK9 and LOX-1 in apoE(-/-) mice
por: Yan, Li, et al.
Publicado: (2021)

Structure-based Design Targeted at LOX-1, a Receptor for Oxidized Low-Density Lipoprotein
por: Thakkar, Shraddha, et al.
Publicado: (2015)

VCre/VloxP and SCre/SloxP: new site-specific recombination systems for genome engineering
por: Suzuki, Emiko, et al.
Publicado: (2011)

Association between soluble lectin-like oxidized low-density lipoprotein receptor 1 levels and coronary slow flow phenomenon
por: Caglar, Ilker Murat, et al.
Publicado: (2016)

Progression of coronary atherosclerosis in patients without standard modifiable risk factors
por: Mazhar, Jawad, et al.
Publicado: (2020)

LOX-1 and Its Splice Variants: A New Challenge for Atherosclerosis and Cancer-Targeted Therapies
por: Rizzacasa, Barbara, et al.
Publicado: (2017)

Lipidomics Profiling and Risk of Coronary Artery Disease in the BioHEART-CT Discovery Cohort
por: Zhu, Dantong, et al.
Publicado: (2023)

High-Density Lipoprotein Prevents Endoplasmic Reticulum Stress-Induced Downregulation of Liver LOX-1 Expression
por: Hong, Dan, et al.
Publicado: (2015)

Plasma soluble lectin-like oxidized low-density lipoprotein receptor-1 acts as a new biomarker for NSTEMI and STEMI patients
por: Sheikh, Md Sayed Ali
Publicado: (2022)

A hierarchical approach to removal of unwanted variation for large-scale metabolomics data
por: Kim, Taiyun, et al.
Publicado: (2021)

Soluble Host-Defense Lectins
por: Matsushita, Misao, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tmamlvo5e99g5an64uoe4rvbdf